10 insiders reported 14 Form 4 transactions for ONCOLYTICS BIOTECH INC (ONCY) over the past 18 months (most recent 2026-03-13). Recent activity: Kelly Jared (Chief Executive Officer) Buy 5,050 shares, Parsons James T. (Director) Buy 10,000 shares, Aromando Andrew (Chief Business Officer) Buy 29,600 shares, Pisano Wayne (Director) Buy 30,000 shares, Heineman Thomas Charles (Chief Medical Officer) Buy 12,132 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-13 | Kelly Jared | Chief Executive Officer | Buy | 5,050 | $4,848 |
| 2026-03-13 | Parsons James T. | Director | Buy | 10,000 | $10,300 |
| 2026-02-13 | Aromando Andrew | Chief Business Officer | Buy | 29,600 | $25,456 |
| 2026-02-13 | Pisano Wayne | Director | Buy | 30,000 | $25,200 |
| 2026-02-13 | Heineman Thomas Charles | Chief Medical Officer | Buy | 12,132 | $10,070 |
| 2026-02-13 | Hagerman Allison | VP, Product Development | Buy | 10,000 | $8,300 |
| 2026-02-13 | Seizinger Bernd R. | Director | Buy | 60,000 | $49,800 |
| 2026-02-13 | Seizinger Bernd R. | Director | Buy | 40,000 | $34,000 |
| 2026-02-13 | Kelly Jared | Chief Executive Officer | Buy | 5,600 | $4,704 |
| 2026-02-13 | Kelly Jared | Chief Executive Officer | Buy | 29,500 | $24,780 |
| 2026-02-13 | Andrews Patricia S | Director | Buy | 35,400 | $30,444 |
| 2026-02-13 | Look Kirk | Chief Financial Officer | Buy | 12,000 | $10,080 |
| 2026-02-13 | Brown Deborah Margaret | Director | Buy | 25,000 | $21,250 |
| 2026-01-20 | Seizinger Bernd R. | Director | Buy | 100,000 | $104,000 |
Source: SEC Form 4 filings · as of 2026-03-13